Overview
Neonatal acquired neutropenia is a condition characterized by abnormally low neutrophil counts in newborns, often associated with maternal hypertension during pregnancy. This condition can persist from shortly after birth up to several weeks and is linked to intrauterine growth retardation, prematurity, and severe maternal hypertension or HELLP syndrome 1.Diagnosis
Key Diagnostic Criteria: Neutrophil count below the reference range for neonates 1.
Recommended Tests: Complete blood count (CBC) with differential to confirm neutropenia 1.
Additional Investigations: Kinetic studies of neutrophils and their progenitors to assess production rates 1.
Risk Factors: Premature birth, intrauterine growth retardation, severe maternal hypertension, and HELLP syndrome 1.Management
First-Line Treatment: Supportive care, including close monitoring for infections and prophylactic antibiotics if indicated 1.
Adjunctive Measures: G-CSF (granulocyte colony-stimulating factor) may be considered to stimulate neutrophil production, though specific dosing is not detailed in the abstract 1.Special Populations
Pregnancy: Neonates born to mothers with hypertension during pregnancy are at higher risk 1.
Premature Infants: Increased prevalence noted in premature newborns 1.Key Recommendations
Closely monitor neonates born to mothers with hypertension for signs of neutropenia, especially those with prematurity or intrauterine growth retardation (Evidence: Moderate 1).
Implement prophylactic measures against infections in neonates diagnosed with neutropenia due to maternal hypertension (Evidence: Moderate 1).
Consider granulocyte colony-stimulating factor (G-CSF) therapy to support neutrophil production in neonates with significant neutropenia (Evidence: Expert opinion 1).References
1 Koenig JM, Christensen RD. Incidence, neutrophil kinetics, and natural history of neonatal neutropenia associated with maternal hypertension. The New England journal of medicine 1989. link